4. TRIAL TREATMENT 4.1 Identity of the investigational product TG01 is a sterile lyophilisate consisting of a mixture of seven peptides. The finished product is a white powder for injection, consisting only of the active substances containing 2.1 mg of peptides (individual peptides comprising 0.3 mg each) .